Ataxia telangiectasia mutated (ATM), could it be another useful biomarker for the successful treatment with the poly (ADP-ribose) polymerase inhibitor?

Suk Young Lee; Sang Cheul Oh

doi:10.21037/tgh.2016.03.12

Ataxia telangiectasia mutated (ATM), could it be another useful biomarker for the successful treatment with the poly (ADP-ribose) polymerase inhibitor?

Suk Young Lee, Sang Cheul Oh

Department of Biomedical Sciences

Research output: Contribution to journal › Editorial › peer-review

1 Citation (Scopus)

Original language	English
Journal	Translational Gastroenterology and Hepatology
Volume	2016
Issue number	MAR
DOIs	https://doi.org/10.21037/tgh.2016.03.12
Publication status	Published - 2016

ASJC Scopus subject areas

Hepatology
Gastroenterology

Access to Document

10.21037/tgh.2016.03.12

Cite this

@article{59dbcd5e938044e1b55e4adc3f14dce1,

title = "Ataxia telangiectasia mutated (ATM), could it be another useful biomarker for the successful treatment with the poly (ADP-ribose) polymerase inhibitor?",

author = "Lee, {Suk Young} and Oh, {Sang Cheul}",

year = "2016",

doi = "10.21037/tgh.2016.03.12",

language = "English",

volume = "2016",

journal = "Translational Gastroenterology and Hepatology",

issn = "2224-476X",